CSF2 and atherosclerosis: These insights have translational implications: targeting metabolic regulatory molecules particularly LXR pathways may offer novel strategies to modulate maladaptive inflammation in GM-CSF involved chronic inflammatory diseases such as atherosclerosis and rheumatic diseases.